Insights (EMCDDA)
(25) Prison and drugs in Europe: current and future challenges (2021) (24) Drug treatment expenditure: a methodological overview (2017) (23) Hepatitis C among drug...
Manuals (EMCDDA)
(13) Implementing quality standards for drug services and systems: a six-step guide to support quality assurance (2021) (12) Increasing access to hepatitis C testing...
ESPAD Report
The European School Survey Project on Alcohol and Other Drugs (ESPAD) (2019) The European School Survey Project on Alcohol and Other Drugs (ESPAD) (2015)...
Drugs and the darknet (EMCDDA, Europol)
Drugs and the darknet. Perspectives for enforcement, research and policy (2017)
EU Drug Markets Report (EMCDDA, Europol)
EU Drug Markets Report (2019) EU Drug Markets Report (2016) (In-depth Analysis) EU Drug Markets Report (2013) (A Strategic Analysis)
Health and social responses to drug problems: a European guide
Health and social responses to drug problems: a European guide Health and social responses to drug problems: a European guide (in Bulgarian)
Risk assessments (EMCDDA)
(35) Report on the risk assessment of 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-chloromethcathinone, 3-CMC) in accordance with Article 5c of Regulation (EC) No 1920/2006 (2022) (34) Report on...
Selected Issues (EMCDDA)
(37) Prisons and drugs in Europe: the problem and responses (2012) (36) Pregnancy, childcare and the family: key issues for Europe’s response to drugs...
65th meeting of Reitox Heads of National Focal Points
The 65th meeting of the Heads of National Focal Points of the European information network on drugs and drug addiction (REITOX) was held in...
Drugnet Europe (Newsletter of the European Monitoring Centre for Drugs and Drug Addiction)
(100) Drugnet Europe – Newsletter of the EMCCDA (October – December 2017) (99) Drugnet Europe – Newsletter of the EMCDDA (July – September 2017)...